Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,282,089 | 1,224,509 | 1,223,195 | 1,196,980 | 1,162,801 |
| Cost of Goods | 530,814 | 507,290 | 507,668 | 504,199 | 515,867 |
| Gross Profit | 751,275 | 717,219 | 715,527 | 692,781 | 646,934 |
| Operating Expenses | 334,032 | 329,907 | 334,311 | 318,197 | 307,612 |
| Operating Income | 417,243 | 387,312 | 381,216 | 374,584 | 339,322 |
| Other Income | 1,079 | -3,815 | -23,484 | 837 | -79,868 |
| Pre-tax Income | 418,322 | 383,497 | 357,732 | 375,421 | 259,454 |
| Income Tax | 73,700 | 72,142 | 65,496 | 74,929 | 50,654 |
| Net Income Continuous | 344,622 | 311,355 | 292,236 | 300,492 | 208,800 |
| Net Income | $344,622 | $311,355 | $292,236 | $300,492 | $208,800 |
| EPS Basic Total Ops | 0.24 | 0.21 | 0.20 | 0.20 | 0.14 |
| EPS Basic Continuous Ops | 0.24 | 0.21 | 0.20 | 0.20 | 0.14 |
| EPS Diluted Total Ops | 0.23 | 0.21 | 0.20 | 0.20 | 0.14 |
| EPS Diluted Continuous Ops | 0.23 | 0.21 | 0.20 | 0.20 | 0.14 |
| EBITDA(a) | $473,145 | $441,022 | $362,356 | $429,226 | $392,692 |